trending Market Intelligence /marketintelligence/en/news-insights/trending/U1DUYeRpS8Y1qOpucgRalQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Gresham House Ventures backs Cisiv

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief


Gresham House Ventures backs Cisiv

Gresham House Ventures invested in technology company Cisiv Ltd. using funds from Baronsmead Venture Capital Trusts.

Cisiv provides electronic data capture, management and analytics to pharmaceutical companies and clinical research organizations.

The investment, made alongside current sponsor Albion Capital Group LLP, will aid the company as it develops its technology and expands its presence in the U.S., including setting up a sales team in the country.

Gresham House Ventures supports businesses with equity of up to £5 million. It is part of the strategic equity division of asset investment manager Gresham House PLC.